Literature DB >> 1896211

Preparative surgery enhances the direct spinal actions of three injectable anaesthetics in the anaesthetized rat.

Nick A Hartell1, Max P Headley.   

Abstract

In this study we have investigated the influence of preparative surgery on the potency with which a range of injectable anaesthetics depressed nociceptive withdrawal reflexes in anaesthetized, spinalized rats. Drug effects were compared on 2 different preparations, each requiring differing degrees of preparatory surgery. Recordings were made in each case of unitary motoneurone responses to controlled noxious stimuli. The dose-dependent effects of the general anaesthetics alpha-chloralose (20-80 mg/kg i.v.) and alphaxalone/alphadolone (0.5-2 mg/kg) and of the dissociative anaesthetic ketamine (0.5-16 mg/kg) were studied. When the degree of surgical intervention was increased, the reflex response to a uniform mechanical pinch stimulus was facilitated. This enhanced response was more susceptible to the reflex depressant actions of all the compounds studied.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1896211     DOI: 10.1016/0304-3959(91)90036-W

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  3 in total

1.  Effects of morphine on visceral nociception evoked by colorectal distension in rats: comparative examinations of electrophysiological and behavioral responses.

Authors:  Sumio Tsukahara; Luke M Kitahata; Kengo Nishioka; Yasuo Ide; Jerry G Collins
Journal:  J Anesth       Date:  1995-09       Impact factor: 2.078

2.  Functional evidence for multiple receptor activation by kappa-ligands in the inhibition of spinal nociceptive reflexes in the rat.

Authors:  J F Herrero; P M Headley
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

3.  Endogenous modulation of excitatory amino acid responsiveness by tachykinin NK1 and NK2 receptors in the rat spinal cord.

Authors:  B A Chizh; M J Cumberbatch; P J Birch; P M Headley
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.